Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENIPNEUMO: Penicillin V vs Amoxicillin in CAP
NCT03208361Phase 3Terminated
- Sponsor
- IDIAPJGol
- Start
- Nov 2013
- Primary completion
- Mar 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of phenoxymethylpenicillin in community acquired pneumonia (CAP), sponsored by IDIAPJGol. Started Nov 2013; status: terminated.
02
Drugs
phenoxymethylpenicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT03208361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208361.